Related Experiment Video
Updated: May 25, 2026

07:32
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Liposome-encapsulated polyethylenimine/oligonucleotide polyplexes prepared by reverse-phase evaporation technique
1Department of Pharmacy, Mokpo National University, 1666 Youngsan-ro, Muan-gun, Jeonnam-do, 534-729, South Korea. youngtakko@mokpo.ac.kr
AAPS Pharmscitech
|February 14, 2012
Summary
We developed a new method for creating liposome-encapsulated polyplexes for oligonucleotide therapeutics. This technique offers a stable and efficient delivery system for nucleic acid drugs.
Area of Science:
- Biotechnology
- Materials Science
- Nanotechnology
Background:
- Liposome-encapsulated polyplexes are promising for delivering oligonucleotide therapeutics like siRNA and asODN.
- Existing methods for preparing these systems require optimization for efficiency and stability.
Purpose of the Study:
- To develop a novel method for preparing liposome-encapsulated cationic polymer/oligonucleotide polyplexes.
- To characterize the resulting particles for their stability, loading efficiency, and protective capabilities.
Main Methods:
- Polyplexes of polyethylenimine and oligonucleotide were formed in aqueous buffer.
- Anionic phospholipids were used in organic media to form inverted micelle-like particles with polyplex cores.
- Reverse-phase evaporation with hydrophilic polymer-grafted lipids yielded stable, lipid-coated particles.
Main Results:
- Transmission electron microscopy confirmed spherical particles with polyplex cores and lipid coats.
- The lipid-coated polyplex particles demonstrated colloidal stability.
- Complete protection of oligonucleotide molecules from enzymatic degradation was observed.
- High loading efficiency exceeding 80% was achieved.
Conclusions:
- The novel reverse-phase evaporation method provides an effective way to create liposome-encapsulated polyplexes.
- This technique offers a viable alternative for producing lipid-coated polyplex particles for oligonucleotide therapeutics delivery.

